Skip Navigation


JAC Advance Access originally published online on January 13, 2005
Journal of Antimicrobial Chemotherapy 2005 55(2):143-149; doi:10.1093/jac/dkh513
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/2/143    most recent
dkh513v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Howell-Jones, R. S.
Right arrow Articles by Thomas, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howell-Jones, R. S.
Right arrow Articles by Thomas, D. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

JAC vol.55 no.2 © The British Society for Antimicrobial Chemotherapy 2005; all rights reserved

Review

A review of the microbiology, antibiotic usage and resistance in chronic skin wounds

R. S. Howell-Jones1,2, M. J. Wilson2, K. E. Hill1,3, A. J. Howard4, P. E. Price3,5 and D. W. Thomas1,2,5

1 Wound Biology Group, Wales College of Medicine, Cardiff University, Cardiff CF14 4XY; 2 Department of Oral Surgery, Medicine and Pathology, Wales College of Medicine, Cardiff University, Cardiff CF14 4XY; 3 Wound Healing Research Unit, Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ; 4 Infection and Communicable Disease Service, National Public Health Service for Wales, Temple of Peace and Health, Cardiff CF10 3NW; 5 Cardiff Institute of Tissue Engineering and Repair, Cardiff University, Cardiff CF14 4XY, UK


* Corresponding author. Tel: +44-29-2074-4252; Fax: +44-29-2074-2442;Email: howell-jonesrs{at}cf.ac.uk

Chronic leg and foot wounds represent an increasing burden to healthcare systems as the age of the population increases. The deep dermal tissues of all chronic wounds harbour microorganisms, however, the precise interaction between microbes in the wounds and impaired healing is unknown. With regard to antibiotic therapy, there is a lack of evidence concerning its effectiveness, optimal regimens or clinical indications for treatment. Despite this lack of evidence, antibiotics are frequently a feature of the management of chronic wounds and these patients receive significantly more antibiotic prescriptions (both systemic and topical) than age and sex-matched patients. Current guidelines for antibiotic prescribing for such wounds are often based on expert opinion rather than scientific fact and may present difficulties in interpretation and implementation to the clinician. Although the increasing prevalence of antibiotic resistance is widely recognized, the relationships between antibiotic resistance, chronic wound microbiology and rationales for antibiotic therapy have yet to be determined. This review discusses the role of microbes in chronic wounds from a clinical perspective with particular focus on the occurrence of bacteria and their impact on such wounds. The evidence and role of antibiotics in the treatment of such wounds are outlined and current practice of antibiotic usage for chronic wounds in the primary care setting described. The implications of antibiotic usage with regard to antibiotic resistance are also considered.

Keywords: wound infection , wound healing , antibacterials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
F. Jacobsen, A. Mohammadi-Tabrisi, T. Hirsch, D. Mittler, P. H. Mygind, C. P. Sonksen, D. Raventos, H. H. Kristensen, S. Gatermann, M. Lehnhardt, et al.
Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin
J. Antimicrob. Chemother., March 1, 2007; 59(3): 493 - 498.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Poole
Efflux-mediated antimicrobial resistance
J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.